Epidemiological and cost analysis of multidrug-resistant tuberculosis in Oman
EMHJ-Eastern Mediterranean Health Journal. 2008; 14 (6): 1238-1243
em Inglês
| IMEMR
| ID: emr-157267
ABSTRACT
We conducted an epidemiological and cost analysis for all 13 patients diagnosed with multaidrug-resistant tuberculosis [11 pulmonary, 2 extrapulmonary] in Oman from January 2000 to October 2005. The disease was secondary, or acquired, in 12 of 13 patients. A total of 140 contacts were screened [mean 10.8 persons per patient], but contact tracing revealed no secondary cases. The mean number of drugs that TB isolates were resistant to was 2.8 [range 2-5]. A mean of 4.7 drugs were given to patients, the mean length of therapy was 8 months and all patients were cured. The cost of medications for these multidrug-resistant cases was 14 to 29 times higher than that for the standard drug-sensitive TB regimen
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Prevalência
/
Estudos Retrospectivos
/
Fatores de Risco
/
Tuberculose Resistente a Múltiplos Medicamentos
/
Custos e Análise de Custo
/
Diagnóstico Precoce
Tipo de estudo:
Avaliação Econômica em Saúde
/
Estudo de prevalência
/
Estudo de rastreamento
Limite:
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
East Mediterr Health J.
Ano de publicação:
2008
Similares
MEDLINE
...
LILACS
LIS